FDA Inspection 1254697 — Carter BloodCare - Alliance

Carter BloodCare - Alliance — FEI 3004061681

The FDA completed an inspection of Carter BloodCare - Alliance on November 15, 2024 in Fort Worth, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 15, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fort Worth, TX (United States)